Mineralys Therapeutics 2026 annual meeting results: directors elected, auditor ratified

Mineralys Therapeutics, Inc.

Elected three Class III directors to serve until 2029: Akkaraju (67.1M for), Slingsby (67.1M for), Karydas (66.6M for).
Ratified Ernst & Young as independent auditor for fiscal year 2026 with 72.6M votes for, 9.5K against.
Broker non-votes of 5.6M shares on director election proposals; no non-votes on auditor ratification.
All proposals passed with requisite affirmative votes as described in the April 8, 2026 proxy statement.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Mineralys Therapeutics, Inc. shareholders approved Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-05-21 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-05-21

Exact text from the filing

Proposal 2 — To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. For Against Abstain Broker Non-Votes 72,648,272 9,516 27,265 0

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Mineralys Therapeutics, Inc. shareholders approved Election of three Class III directors for a three-year term expiring at the 2029 annual meeting at the 2026-05-21 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-05-21

Exact text from the filing

Proposal 1 — To elect three directors to serve as Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders. Name For Withhold Broker Non-Votes Srinivas Akkaraju, M.D., Ph.D. 40,667,555 26,447,538 5,569,960 Brian Taylor Slingsby, M.D., Ph.D., M.P.H. 42,487,140 24,627,953 5,569,960 Daphne Karydas 66,626,766 488,327 5,569,960

View on SEC.gov

Browse all shareholder votes →

Mineralys Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001933414-26-000090

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.